跳至主要内容
临床试验/IRCT20240521061860N1
IRCT20240521061860N1招募中3 期

Investigating the effect of curcumin supplementation on depression, anxiety, pain and BDNF serum concentration in patients with gastrointestinal cancer

Zahedan University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Male

入选标准

  • Men over 18 years old with gastrointestinal cancers
  • At least 6 months have passed since the onset of the disease.
  • They must meet the depression criteria according to DSM-5 criteria
  • They must be willing to participate in the study.
  • do not have any contraindications for prescribing curcumin.
  • No previous use of pharmaceutical antidepressants, no use of cigarettes and curcumin supplements.

排除标准

  • People who are in the end stage of cancer.
  • Do not want to participate in the study.
  • Do not have depression criteria.
  • Patients under 18 years old
  • Patients with panic disorder, bipolar disorder, co morbid obsessive-compulsive disorder, post traumatic stress disorder, eating disorder, or any substance abuse or dependence disorder and people at high risk of suicide.
  • Patients with medical diseases such as diabetes, autoimmune diseases, cardiovascular diseases, high blood pressure, Alzheimer's disease, Parkinson's disease, stroke and multiple sclerosis, chronic fatigue syndrome, fibromyalgia and asthma.

研究者

发起方
Zahedan University of Medical Sciences

相似试验